Mei-Ching Liu

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.7K citations · Full text

Chemotherapy Versus Placebo, Breast Oncology, Oncology +7

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

Carlos H. Barrios, Mei-Ching Liu, Soo Chin Lee et al. · Breast Cancer Research and Treatment · 2010 · 196 citations · Full text

Unique features of breast cancer in Taiwan

Skye Hongiun Cheng, Mei-Hua Tsou, Mei-Ching Liu et al. · Breast Cancer Research and Treatment · 2000 · 103 citations

Breast Oncology, Medicine, Pathology +4

Adherence to Quality Indicators and Survival in Patients With Breast Cancer

Skye Hung‐Chun Cheng, C Jason Wang, Lin Jinlong et al. · Medical Care · 2009 · 74 citations

Clinicopathological analysis of 598 malignant lymphomas in Taiwan: Seven-year experience in a single institution

Ming-Yuan Lee, Tran‐Der Tan, An‐Chen Feng et al. · American Journal of Hematology · 2006 · 48 citations

Pathology, Seven-year Experience, Malignant Lymphomas +17